Walleye Capital LLC Silk Road Medical Inc Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$16.95 - $27.04 $117,734 - $187,819	6,946 New	6,946 $187,000
Q4 2023 Feb 14, 2024	BUY	$6.29 - $15.72 $676,432 - $1.69 Million	107,541 Added 755.73%	121,771 $1.49 Million
Q3 2023 Nov 14, 2023	BUY	$14.99 - $32.65 $213,307 - $464,609	14,230 New	14,230 $213,000
Q1 2023 May 15, 2023	BUY	$38.09 - $57.79 $280,570 - $425,681	7,366 New	7,366 $288,000
Q3 2021 Nov 15, 2021	SELL	$44.0 - $65.8 $385,000 - $575,750	-8,750 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$44.66 - $63.06 $390,774 - $551,775	8,750 New	8,750 $419,000
Q4 2020 Feb 16, 2021	SELL	$55.51 - $69.94 $644,637 - $812,213	-11,613 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$42.19 - $69.61 $489,952 - $808,380	11,613 New	11,613 $781,000

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.